Patent intelligence · CN
CN 112638413
Oral immunotherapy unit dose dispensing systems and methods
Oral immunotherapy unit dose dispensing systems and methods
Patent details — CN 112638413
- Jurisdiction
- CN
- Status
- granted
- Grant date
- Apr 9, 2021
- Expiration
- Apr 4, 2041
- Applicant
- ALLERGEN RES CORPORATION
- CPC classes
- A61K 39/ 35 A I, A61K 39/ 36 A I, A61K 47/ 22 A I, A61K/914
Quick answer
CN 112638413 (Oral immunotherapy unit dose dispensing systems and methods) is held by ALLERGEN RES CORPORATION. Status: granted. Granted Apr 9, 2021. Expires Apr 4, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALLERGEN RES CORPORATION
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 39/ 35 A I, A61K 39/ 36 A I, A61K 47/ 22 A I, A61K/914, A61K/920
More from ALLERGEN RES CORPORATION
Related pharmaceutical patents in our USPTO index.
-
WO 2015187736
FORMULATIONS PLACEBO ET UTILISATIONS DE CELLES-CI
granted -
US 2014356438
PERIPHERALLY ADMINISTERED VISCOUS FORMULATIONS
granted -
US 2014271721
PEANUT FORMULATIONS AND USES THEREOF
granted -
US 2014271836
MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
granted -
US 2013209398
CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS AND METHODS OF USE
granted -
CA 2849366
COMPOSITIONS ET PROCEDES POUR TRAITER LA PRESBYTIE, L'HYPERMETROPIE LEGERE ET L'ASTIGMATISME IRREGULIER
granted -
US 2012003230
SUSTAINED RELEASE DRUG DELIVERY SYSTEMS COMPRISING A WATER SOLUBLE THERAPEUTIC AGENT AND A RELEASE MODIFIER
granted
Frequently asked questions
What is US patent 112638413?
CN 112638413 (Oral immunotherapy unit dose dispensing systems and methods) is held by ALLERGEN RES CORPORATION. Status: granted. Granted Apr 9, 2021. Expires Apr 4, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CN 112638413?
ALLERGEN RES CORPORATION is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 24 pharmaceutical patents for this assignee.
When does CN 112638413 expire?
Our index shows an expiration date of Apr 4, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.